Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment

Go back to Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
(AMEX: AVAI) Delayed: 0.12 +0.01 (9.09%)
Previous Close $0.11    52 Week High
Open $0.13    52 Week Low
Day High $0.13    P/E N/A 
Day Low $0.12    EPS
Volume 60,371